0001206774-24-000281.txt : 20240321 0001206774-24-000281.hdr.sgml : 20240321 20240321092655 ACCESSION NUMBER: 0001206774-24-000281 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240321 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240321 DATE AS OF CHANGE: 20240321 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CLOROX CO /DE/ CENTRAL INDEX KEY: 0000021076 STANDARD INDUSTRIAL CLASSIFICATION: SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 310595760 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07151 FILM NUMBER: 24769744 BUSINESS ADDRESS: STREET 1: THE CLOROX COMPANY STREET 2: 1221 BROADWAY CITY: OAKLAND STATE: CA ZIP: 94612-1888 BUSINESS PHONE: 5102717000 MAIL ADDRESS: STREET 1: P.O. BOX 24305 CITY: OAKLAND STATE: CA ZIP: 94612-1305 8-K 1 clx431282-8k.htm CURRENT REPORT
false 0000021076 0000021076 2024-03-21 2024-03-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 21, 2024

 

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of incorporation)

1-07151
(Commission File Number)

31-0595760
(I.R.S. Employer
Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices)    (Zip code)

(510271-7000
(Registrant's telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock - $1.00 par value CLX New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company         

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.        ¨

 

 

 

Item 7.01 Regulation FD Disclosure.

On March 21, 2024, The Clorox Company (“Clorox”) issued a press release announcing the sale of its operations in Argentina, Uruguay and Paraguay. The full text of the press release related to the sale is attached hereto as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits
   
See the Exhibit Index below.

EXHIBIT INDEX

Exhibit Description

 

99.1 Press Release dated March 21, 2024 of The Clorox Company
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  THE CLOROX COMPANY
   
Date:  March 21, 2024 By:    /s/ Angela Hilt
  Angela Hilt
  Executive Vice President – Chief Legal Officer
   

 

3

 

EX-99.1 CHARTER 2 clx431282-ex991.htm PRESS RELEASE DATED MARCH 21, 2024 OF THE CLOROX COMPANY

Exhibit 99.1

PRESS RELEASE  
     

Clorox Divests its Operations in Argentina, Uruguay and Paraguay

 Sale advances Clorox’s IGNITE strategy to evolve its portfolio for long term profitable growth  

OAKLAND, Calif., March 21, 2024 — The Clorox Company (NYSE: CLX) (the “company” or “Clorox”) today announced the sale of certain wholly owned subsidiaries (collectively, “Clorox Argentina”), with operations in Argentina, Uruguay and Paraguay, to Apex Capital, a private equity fund associated with Grupo Mariposa, a 139-year old food and beverage company with operations in 16 countries, and an investment group led by Diego Barral, former senior vice president and general manager of International at Clorox. Financial terms were not disclosed. 

The transaction included Clorox Argentina’s two production plants, as well as rights to certain Clorox brands in Argentina, Uruguay and Paraguay and shared intellectual property across those brands. The transaction does not include Clorox’s Latin America research and development and corporate hubs, which will remain in Argentina to support Clorox’s ongoing operations in other Latin American markets and provide transitional services to Clorox Argentina under its new ownership. Clorox Argentina’s employees, including all production staff, will remain employed by Clorox Argentina (to be renamed and operate under the name of “Grupo Ayudin”) except for employees dedicated to the R&D and corporate hubs, who will remain with Clorox under a new corporate structure in Argentina.

“This transaction supports our IGNITE strategy and our commitment to evolve our portfolio to increase our focus on our core business to drive more consistent, profitable growth,” said Chair and CEO Linda Rendle. “I would like to thank our teammates in Argentina for effectively managing the business in this dynamic operating environment. The new owners share our values and bring proven local operating experience and we believe their focus on maximizing the potential of the business will position it to deliver continued growth that benefits consumers and employees.” 

Clorox Argentina represents approximately 2% of the company’s fiscal year 2024 net sales outlook provided in the most recent February 2024 earnings release. As a result of this transaction, the company will incur a one-time, after-tax charge of approximately $233 million in the third quarter of fiscal year 2024 (or approximately a $1.87 reduction to earnings per share). The vast majority of this charge is driven by the non-cash release of approximately $222 million of accumulated currency translation previously recorded in equity. This transaction is expected to reduce the company’s fiscal year 2024 net sales growth by approximately half a point and adjusted earnings per share by $0.00 to $0.02 cents. The company is not otherwise reiterating any prior guidance.

About The Clorox Company
The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its trusted brands, which include Brita®, Burt’s Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, Pine-Sol® and Natural Vitality®, can be found in about nine of 10 U.S. homes and internationally with brands such as Ayudin®, Clorinda®, Chux® and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first in the U.S. to integrate ESG into its business reporting. In 2024 the company was ranked No. 1 on Barron’s 100 Most Sustainable Companies list for the second consecutive year. Visit thecloroxcompany.com to learn more.

Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements regarding the expected or potential impact of the company’s operational disruption stemming from a cyberattack, and any such forward-looking statements involve risks, assumptions and uncertainties. Except

 

 

for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management’s estimates, beliefs, assumptions and projections. Words such as “could,” “may,” “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “will,” “predicts,” and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations, are described in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023, and in the company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023, and as updated from time to time in the company’s Securities and Exchange Commission filings. These factors include, but are not limited to: our recovery from the cyberattack, unfavorable general economic and geopolitical conditions beyond our control, including supply chain disruptions, labor shortages, wage pressures, rising inflation, the interest rate environment, fuel and energy costs, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, such as COVID-19, terrorism, and unstable geopolitical conditions, including ongoing conflicts in the Middle East and Ukraine and rising tensions between China and Taiwan, as well as macroeconomic and geopolitical volatility and uncertainty as a result of a number of these and other factors, including actual and potential shifts between the U.S. and its trading partners, especially China; volatility and increases in the costs of raw materials, energy, transportation, labor and other necessary supplies or services; the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences; the ability of the company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix; risks related to supply chain issues, product shortages and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers; intense competition in the company’s markets; the ability of the company to implement and generate cost savings and efficiencies, and successfully implement its transformational initiatives or strategies, including achieving anticipated benefits and cost savings from the implementation of the streamlined operating model and digital capabilities and productivity enhancements; dependence on key customers and risks related to customer consolidation and ordering patterns; the ability of the company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity; risks related to international operations and international trade, including changing macroeconomic conditions as a result of inflation, volatile commodity prices and increases in raw and packaging materials prices, labor, energy and logistics; global economic or political instability; foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls; changes in governmental policies, including trade, travel or immigration restrictions, new or additional tariffs, and price or other controls; labor claims and civil unrest; continued high levels of inflation in Argentina; risks relating to acquisitions, new ventures and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets, including trademarks and goodwill, in particular the impairment charges related to the carrying value of the company’s Vitamins, Minerals and Supplements business and the divestiture of and related loss on sale from our operations in Argentina; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions; the accuracy of the company’s estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based; risks related to increases in the estimated fair value of The Procter & Gamble Company’s interest in the Glad business; the performance of strategic alliances and other business relationships.

The company’s forward-looking statements in this press release are based on management’s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this press release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.

Non-GAAP Financial Information
This press release contains non-GAAP financial information related to adjusted EPS. Adjusted EPS is defined as diluted earnings per share that excludes or has otherwise been adjusted for significant items that are nonrecurring or unusual. The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income

 

 

tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. Adjusted EPS is supplemental information that management uses to help evaluate the company’s historical and prospective financial performance on a consistent basis over time. Management believes that by adjusting for certain items affecting comparability of performance over time, such as the pension settlement charge, incremental costs related to the cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions or dispositions, and other nonrecurring or unusual items, investors and management are able to gain additional insight into the company’s underlying operating performance on a consistent basis over time. However, adjusted EPS may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.

Clorox Media Contact:
corporate.communications@clorox.com

Clorox Investor Relations Contact:
investorrelations@clorox.com

CLX-F

 

EX-101.SCH 3 clx-20240321.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.PRE 4 clx-20240321_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.LAB 5 clx-20240321_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] GRAPHIC 6 clx431282-8kx1x1x1.jpg GRAPHIC begin 644 clx431282-8kx1x1x1.jpg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clx431282-8kx2x1x1.jpg GRAPHIC begin 644 clx431282-8kx2x1x1.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover
Mar. 21, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 21, 2024
Entity File Number 1-07151
Entity Registrant Name THE CLOROX COMPANY
Entity Central Index Key 0000021076
Entity Tax Identification Number 31-0595760
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1221 Broadway
Entity Address, City or Town Oakland
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94612-1888
City Area Code 510
Local Phone Number 271-7000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock - $1.00 par value
Trading Symbol CLX
Security Exchange Name NYSE
Entity Emerging Growth Company false

EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://thecloroxcompany.com/role/Cover Cover Cover 1 false false All Reports Book All Reports clx-20240321.xsd clx-20240321_lab.xml clx-20240321_pre.xml clx431282-8k.htm clx431282-8kx1x1x1.jpg http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "clx431282-8k.htm": { "nsprefix": "CLX", "nsuri": "http://thecloroxcompany.com/20240321", "dts": { "schema": { "local": [ "clx-20240321.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "clx-20240321_lab.xml" ] }, "presentationLink": { "local": [ "clx-20240321_pre.xml" ] }, "inline": { "local": [ "clx431282-8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://thecloroxcompany.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-21", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "clx431282-8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-21", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "clx431282-8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://thecloroxcompany.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001206774-24-000281-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001206774-24-000281-xbrl.zip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end XML 19 clx431282-8k_htm.xml IDEA: XBRL DOCUMENT 0000021076 2024-03-21 2024-03-21 iso4217:USD shares iso4217:USD shares false 0000021076 8-K 2024-03-21 THE CLOROX COMPANY DE 1-07151 31-0595760 1221 Broadway Oakland CA 94612-1888 510 271-7000 false false false false Common Stock - $1.00 par value CLX NYSE false